DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
Aims To explore the cost-effectiveness of alternative methods of screening family members for hypertrophic cardiomyopathy (HCM), the most common monogenic cardiac disorder and the most frequent cause of sudden cardiac death (SCD) in young people. Methods and results Economic decision model comparing...
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Idioma: | English |
| Publicat: |
2010
|
Search Result 1
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model
Publicat 2010
Journal article